Brind.

The ECLIPSE program is the registrational program for Vir Biotechnology, and the trial supports global marketing in Europe.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Firefly Aerospace VIR Biotechnology

Keep exploring

The entities involved

Firefly Aerospace
private aerospace firm based in US
- A company involving Firefly Aerospace and Abbott is operating from its campus in Cedar Park, Texas.Mon 06:43
- Blue Origin, Firefly, and ASTROLab are contributing components and services for the new lunar outpost under the Artemis program.Sat 20:40
VIR Biotechnology
biotech company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 31Business WireVir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the swi